ash 2019 interview - prof peter hillmen - treatment – patient choice
Published 4 years ago • 71 plays • Length 1:22Download video MP4
Download video MP3
Similar videos
-
1:08
ash 2019 interview - prof peter hillmen - challenges in the cll/sll treatment landscape
-
2:34
ash 2019 interview - prof peter hillmen - cll updates from ash 2019
-
7:31
ash 2019 interview - prof miles prince – genetic testing (cll/sll) & car t-cell therapy
-
9:06
ash 2019 interview - prof andrew evens - holistic hodgkin lymphoma international study
-
20:30
ash 2019 - roundtable day 1 - patient advocacy at ash 2019
-
2:11
ash 2019 interview - dr sasanka handunnetti - marginal zone lymphoma study
-
30:49
my journey battling cancer (splenic marginal zone lymphoma) -part 1
-
8:20
survivorship: after non-hodgkin lymphoma treatment ends
-
1:22:03
an update hodgkin lymphoma
-
2:35
ash 2019 interview - dr stephen ansell and deborah sims - hodgkin lymphoma
-
4:41
ash 2019 interview - dr katherine lewis - primary central nervous system lymphoma (pcnsl)
-
5:45
ash 2019 interview - dr tanya siddiqi - car t-cell in relapsed/refractory cll
-
1:45
ash 2019 interview - a/prof chan cheah – phase i study tg-1701 relapsed/refractory b-cell lymphoma
-
0:32
an interview with dr. peter hillmen - understanding cll
-
3:18
ash 2019 interview - dr jessica hochberg - chemotherapy, young adults & hodgkin lymphoma
-
4:50
deborah sims and professor peter hillmen discuss data presented at ash
-
1:02:19
late effects and lymphoma survivorship - assoc prof kylie mason
-
4:28
ash 2014: prof john gribben and prof peter hillmen discuss recent advances in cll (part 3)
-
2:00
ash 2019: improving global lymphoma diagnoses
-
20:10
lymphomas in 2024 changing standards of care and challenging paradigms elizabeth brem, md from uci